(NASDAQ: LIN) Linde's forecast annual revenue growth rate of 5.47% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Linde's revenue in 2024 is $32,854,000,000.On average, 5 Wall Street analysts forecast LIN's revenue for 2024 to be $16,601,894,745,587, with the lowest LIN revenue forecast at $16,351,417,190,970, and the highest LIN revenue forecast at $16,944,268,167,320. On average, 5 Wall Street analysts forecast LIN's revenue for 2025 to be $17,641,329,402,752, with the lowest LIN revenue forecast at $17,239,248,685,291, and the highest LIN revenue forecast at $18,041,780,947,008.
In 2026, LIN is forecast to generate $18,547,630,317,926 in revenue, with the lowest revenue forecast at $18,170,100,369,008 and the highest revenue forecast at $18,753,069,396,152.